drugset / Trial / NCT02688465

Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).

NCT02688465

Phase 4 Terminated 15 enrolled Fondation Ophtalmologique Adolphe de Rothschild
NaSingle-groupOpen-labelTreatment

Summary

Parkinson's disease is not only a pathology of movements. There are many non-motor symptoms that complicate and impair patients' quality of life. Among those disorders are sleep disorders. Insomnia is the most frequent symptom. Most patients report 2-5 awakenings per night and long periods of awakening which occupy 30 to 40% of their night. Apomorphine is a dopamine agonist that may be administered with a pump . The objective of the study is to assess changes in the quality of sleep in Parkinson's disease patients treated with an apomorphine pump.

Timeline

Start
2016-09-05
Primary completion
2017-01
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Apomorphine Unknown

Indications